Rheumatology 1999; 38: 831-836
© 1999 British Society for Rheumatology
Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy
1 Nephrology and Rheumatology and
2 Radiology, Klinikum Benjamin Franklin FU,
3 Radiology, Klinikum Charité, Humboldt Universität, Berlin and
4 Deutsches Rheumaforschungszentrum, Berlin, Germany
Correspondence to:
J. Braun, Rheumatologie, Medizinische Klinik und Poliklinik, Klinikum Benjamin Franklin FU Berlin, Hindenburgdamm 30, 12200 Berlin, Germany.
Objective. Clinical and magnetic resonance imaging (MRI) data of 170 consecutive patients with inflammatory back pain (IBP) and/or oligoarthritis of the lower limbs were evaluated in a retrospective study. The aim was to determine the frequency of sacroiliitis and spondyloarthropathy (SpA) in this population, and to assess the significance of HLA B27 measurements for diagnosis in early disease.
Methods. Pelvic X-rays were performed in all IBP patients and dynamic MRI of the sacroiliac joints in patients with IBP who had indefinite results on sacroiliac X-rays (n=32).
Results. European Spondyloarthropathy Study Group criteria for SpA were fulfilled by 106/170 patients (62.4%); eight additional patients had symptoms suggestive of SpA (4.7%). The most frequent SpA subset was undifferentiated SpA (uSpA), diagnosed in 46/106 patients (43.4%). Sacroiliitis was detected by MRI in 21/32 patients with IBP and unclear X-rays (65.6%). Of those, 14 were diagnosed as SpA and seven females with moderate unilateral sacroiliitis, but no features of SpA, also not on follow-up (at least 1 yr), were classified as undifferentiated sacroiliitis (US). Ten of the 14 SpA (71.4%) and none of the seven US patients were HLA B27 positive.
Conclusion. HLA B27 positivity in IBP patients with MRI-proven sacroiliitis positively predicts SpA. uSpA is a frequent SpA subset. There are HLA B27-negative non-SpA patients with moderate unilateral sacroiliitis whom we propose to be classified as US.
KEY WORDS: Spondyloarthropathy, Inflammatory back pain, Oligoarthritis, Sacroiliitis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Elewaut and M. Matucci-Cerinic Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice Rheumatology, June 26, 2009; (2009) kep146v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Sieper, D van der Heijde, R Landewe, J Brandt, R Burgos-Vagas, E Collantes-Estevez, B Dijkmans, M Dougados, M A Khan, M Leirisalo-Repo, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) Ann Rheum Dis, June 1, 2009; 68(6): 784 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Jois, A. J. Macgregor, and K. Gaffney Recognition of inflammatory back pain and ankylosing spondylitis in primary care Rheumatology, September 1, 2008; 47(9): 1364 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. I. Sidiropoulos, G. Hatemi, I.-H. Song, J. Avouac, E. Collantes, V. Hamuryudan, M. Herold, T. K. Kvien, H. Mielants, J. M. Mendoza, et al. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists Rheumatology, March 1, 2008; 47(3): 355 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zochling, J. Brandt, and J. Braun The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis Rheumatology, December 1, 2005; 44(12): 1483 - 1491. [Full Text] [PDF]
|
|
|
|
|
|
C. T. Chou, K. C. Lin, J. C. C. Wei, W. C. Tsai, H. H. Ho, C. M. Hwang, J. M. Cherng, C. M. Hsu, and D. T. Y. Yu Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands Rheumatology, May 1, 2005; 44(5): 662 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Braun, X. Baraliakos, J. Brandt, J. Listing, A. Zink, R. Alten, G. Burmester, E. Gromnica-Ihle, H. Kellner, M. Schneider, et al. Persistent clinical response to the anti-TNF-{alpha} antibody infliximab in patients with ankylosing spondylitis over 3 years Rheumatology, May 1, 2005; 44(5): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Braun and J. Sieper Biological therapies in the spondyloarthritides--the current state Rheumatology, September 1, 2004; 43(9): 1072 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Puhakka, A. G. Jurik, B. Schiottz-Christensen, G. V. O. Hansen, N. Egund, J. V. Christiansen, and K. Stengaard-Pedersen Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings Rheumatology, February 1, 2004; 43(2): 234 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zou, Y. Zhang, A. Thiel, M. Rudwaleit, S.-L. Shi, A. Radbruch, R. Poole, J. Braun, and J. Sieper Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis Rheumatology, July 1, 2003; 42(7): 846 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Braun, D van der Heijde, M Dougados, P Emery, M A Khan, J Sieper, and S. van der Linden Staging of patients with ankylosing spondylitis: a preliminary proposal Ann Rheum Dis, November 1, 2002; 61(90003): iii19 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Sieper and J Braun New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy Ann Rheum Dis, November 1, 2001; 60(90003): iii58 - 61. [Full Text] [PDF]
|
|
|
|
|
|
J Braun, M A Khan, and J Sieper Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response? Ann Rheum Dis, December 1, 2000; 59(12): 985 - 994. [Full Text]
|
|
|
|
|
|
J. Braun, J. Xiang, J. Brandt, H. Maetzel, H. Haibel, P. Wu, S. Kohler, M. Rudwaleit, S. Siegert, A. Radbruch, et al. Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha : first clinical and laboratory experiences Ann Rheum Dis, November 1, 2000; 59(90001): i85 - 89. [Full Text] [PDF]
|
|
|
|
|
|
L. Koehler, J. G. Kuipers, and H. Zeidler Managing seronegative spondarthritides Rheumatology, April 1, 2000; 39(4): 360 - 368. [Full Text] [PDF]
|
|